Which has the lower trailing P/E, AZN or CI?

CI has the lower trailing P/E: AZN trades at 24.05 and CI at 11.62. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AZN or CI?

Over the past five years, AZN grew revenue faster — AZN at a 15.76% CAGR versus CI at 11.11%.

Does AZN or CI pay a bigger dividend?

AZN yields 2.02% and CI yields 2.20% based on trailing dividends and the latest price.

Is AZN or CI more profitable?

AZN runs the higher net margin — AZN at 17.02% versus CI at 2.27%.

How have AZN and CI total returns compared?

Over the past 10 years, AZN delivered 12.85% and CI delivered 9.30% annualized total return. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs Cigna Corporation (CI)

A side-by-side comparison of AstraZeneca PLC and Cigna Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

AZN

AstraZeneca PLC

$248.40B

$160.17HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Cigna Corporation

$74.19B

$280.76HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — AZN vs CI

growth of $100 · dividends reinvested · last 10y

AZN +217.1% (+12.2%/yr)CI +144.8% (+9.4%/yr)AZN compounded faster over this window

AZN CI

AZN vs CI: by the numbers

•AZN is the larger company ($248.40B vs $74.19B market cap).
•CI trades at the lower trailing earnings multiple (11.62 vs 24.05 P/E), one valuation lens rather than an overall verdict.
•AZN converts more revenue to profit (17.02% vs 2.27% net margin).
•AZN grew revenue faster over the past five years (15.76% vs 11.11% CAGR).
•CI pays the higher dividend yield (2.20% vs 2.02%).

Metrics side by side

Valuation

Metric	AZN	CI
P/E ratio	24.05	11.62
Forward P/E	15.64	9.20
P/S ratio	4.05	0.26
P/B ratio	4.94	1.74
EV / EBITDA	13.56	8.08
FCF yield	3.52%	12.28%

Profitability

Metric	AZN	CI
Gross margin	81.88%	11.66%
Operating margin	22.77%	3.46%
Net margin	17.02%	2.27%
ROE	20.79%	15.05%
ROIC	12.83%	7.69%

Dividends

Metric	AZN	CI
Dividend yield	2.02%	2.20%
Payout ratio	48.50%	25.62%

Growth (annualized)

Metric	AZN	CI
Revenue CAGR (5Y)	15.76%	11.11%
EPS CAGR (5Y)	22.02%	-0.76%
FCF CAGR (5Y)	14.53%	-1.95%
Total return CAGR (5Y)	9.46%	8.53%

Frequently asked

Which has the lower trailing P/E, AZN or CI?: CI has the lower trailing P/E: AZN trades at 24.05 and CI at 11.62. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AZN or CI?: Over the past five years, AZN grew revenue faster — AZN at a 15.76% CAGR versus CI at 11.11%.
Does AZN or CI pay a bigger dividend?: AZN yields 2.02% and CI yields 2.20% based on trailing dividends and the latest price.
Is AZN or CI more profitable?: AZN runs the higher net margin — AZN at 17.02% versus CI at 2.27%.
How have AZN and CI total returns compared?: Over the past 10 years, AZN delivered 12.85% and CI delivered 9.30% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full CI analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio Cigna P/E ratio AstraZeneca dividend yield Cigna dividend yield AstraZeneca ROE Cigna ROE AstraZeneca operating margin Cigna operating margin AstraZeneca revenue growth Cigna revenue growth AstraZeneca free cash flow Cigna free cash flow

AstraZeneca & Cigna appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.